| MDL | MFCD26097265 |
|---|---|
| Molecular Weight | 353.81 |
| Molecular Formula | C17H16ClN7 |
| SMILES | CN1C=NC2=C(NC3=CC=C(Cl)C=C3)N=C(N4N=C(C)C=C4C)N=C12 |
NS13001 is a potent, selective, orally active allosteric positive modulator of SK channels (small conductance calcium-activated potassium channels). The EC 50 s are 1.8 and 0.14 μM for SK2 and SK3, respectively. NS13001 holds promise as a potential therapeutic agent for treatment of spinocerebellar ataxia type 2 (SCA2) and possibly other cerebellar ataxias [1] .
EC50: 1.8 μM (SK2), 0.14 μM (SK3) [1]
Solid
Room temperature in continental US; may vary elsewhere.
| Powder | -20°C | 3 years |
|---|---|---|
| 4°C | 2 years | |
| In solvent | -80°C | 6 months |
| -20°C | 1 month |
DMSO : 100 mg/mL ( 282.64 mM ; Need ultrasonic)
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 2.8264 mL | 14.1319 mL | 28.2638 mL |
| 5 mM | 0.5653 mL | 2.8264 mL | 5.6528 mL |
| 10 mM | 0.2826 mL | 1.4132 mL | 2.8264 mL |